NCT06238986View on ClinicalTrials.gov

Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy

TerminatedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

March 22, 2024

Primary Completion Date

November 18, 2024

Study Completion Date

November 18, 2024

Conditions
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (2)

55905

Mayo Clinic in Rochester, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06238986 - Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy | Biotech Hunter | Biotech Hunter